Use in Pregnancy: Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Febuxostat (Urica) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in Lactation: It is not known if Febuxostat (Urica) is excreted in human milk. Since many drugs are excreted in human milk, caution should be exercised when administering Febuxostat (Urica) to breastfeeding women.